Clinical Trial Update: Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adjunct phentermine/topiramate after bariatric surgery in youths aged 12-24 with obesity. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity Morbid

Drugs mentioned

• Phentermine (Phentermine)
• Topiramate (Topiramate)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Obesity, Morbid, Bariatric Surgery | Phase 2 | Status: COMPLETED | Results posted: 2025-05-23